Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Chi

Showing results (841-850 of 903) with videos related to

Pageof 91
Sort By:
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 29, 2025
Basket study of oral progesterone antagonist onapristone extended-release in combination with anastrozole in progesterone receptor-positive recurrent adult-type granulosa cell tumor of the ovaryLindsey Finch, Sarah Andres, Alexia Iasonos, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 14, 2025
Procedural interventions for oligoprogression during treatment with immune checkpoint blockade in gynecologic malignancies: a case seriesTiffany Y Sia, Vivian Wan, Michael Finlan, et al.
Bone Marrow Transplantation|August 12, 2009
Allogeneic hematopoietic cell transplantation for myelodysplastic syndrome: prognostic significance of pre-transplant IPSS score and comorbidityJ-H Lee, J-H Lee, S-N Lim, et al.
Gynecologic Oncology|November 12, 2021
Phase II study of enzalutamide in androgen receptor positive, recurrent, high- and low-grade serous ovarian cancerBeryl L Manning-Geist, Sushmita B Gordhandas, Dilip D Giri, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 31, 2024
Procedural interventions for oligoprogression during treatment with immune checkpoint blockade in gynecologic malignancies: a case seriesTiffany Y Sia, Vivian Wan, Michael Finlan, et al.
Annals of Surgical Oncology|July 7, 2011
A risk model for secondary cytoreductive surgery in recurrent ovarian cancer: an evidence-based proposal for patient selectionWen-Juan Tian, Dennis S Chi, Jalid Sehouli, et al.
Gynecologic Oncology|September 13, 2020
Role of delayed interval debulking for persistent residual disease after more than 5 cycles of chemotherapy for primary advanced ovarian cancer. An international multicenter studyHelmut Plett, Olga T Filippova, Annalisa Garbi, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 21, 2024
ARIA II: a randomized controlled trial of near-infrared Angiography during RectosIgmoid resection and Anastomosis in women with ovarian cancerMario M Leitao, Alexia Iasonos, Morgan Tomberlin, et al.
Gynecologic Oncology|March 16, 2022
Hyperthermic intraperitoneal chemotherapy (HIPEC) with carboplatin induces distinct transcriptomic changes in ovarian tumor and normal tissuesLea A Moukarzel, Lorenzo Ferrando, Higinio Dopeso, et al.
Gynecologic Oncology|November 1, 2025
A pilot study of nivolumab in combination with neoadjuvant and post-surgical chemotherapy in newly diagnosed ovarian cancerSara Moufarrij, Claire F Friedman, Samuel Freeman, et al.
Pageof 91

Showing results (841-850 of 903) with videos related to

Sort By:
Pageof 91
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 29, 2025
Basket study of oral progesterone antagonist onapristone extended-release in combination with anastrozole in progesterone receptor-positive recurrent adult-type granulosa cell tumor of the ovaryLindsey Finch, Sarah Andres, Alexia Iasonos, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 14, 2025
Procedural interventions for oligoprogression during treatment with immune checkpoint blockade in gynecologic malignancies: a case seriesTiffany Y Sia, Vivian Wan, Michael Finlan, et al.
Bone Marrow Transplantation|August 12, 2009
Allogeneic hematopoietic cell transplantation for myelodysplastic syndrome: prognostic significance of pre-transplant IPSS score and comorbidityJ-H Lee, J-H Lee, S-N Lim, et al.
Gynecologic Oncology|November 12, 2021
Phase II study of enzalutamide in androgen receptor positive, recurrent, high- and low-grade serous ovarian cancerBeryl L Manning-Geist, Sushmita B Gordhandas, Dilip D Giri, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 31, 2024
Procedural interventions for oligoprogression during treatment with immune checkpoint blockade in gynecologic malignancies: a case seriesTiffany Y Sia, Vivian Wan, Michael Finlan, et al.
Annals of Surgical Oncology|July 7, 2011
A risk model for secondary cytoreductive surgery in recurrent ovarian cancer: an evidence-based proposal for patient selectionWen-Juan Tian, Dennis S Chi, Jalid Sehouli, et al.
Gynecologic Oncology|September 13, 2020
Role of delayed interval debulking for persistent residual disease after more than 5 cycles of chemotherapy for primary advanced ovarian cancer. An international multicenter studyHelmut Plett, Olga T Filippova, Annalisa Garbi, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 21, 2024
ARIA II: a randomized controlled trial of near-infrared Angiography during RectosIgmoid resection and Anastomosis in women with ovarian cancerMario M Leitao, Alexia Iasonos, Morgan Tomberlin, et al.
Gynecologic Oncology|March 16, 2022
Hyperthermic intraperitoneal chemotherapy (HIPEC) with carboplatin induces distinct transcriptomic changes in ovarian tumor and normal tissuesLea A Moukarzel, Lorenzo Ferrando, Higinio Dopeso, et al.
Gynecologic Oncology|November 1, 2025
A pilot study of nivolumab in combination with neoadjuvant and post-surgical chemotherapy in newly diagnosed ovarian cancerSara Moufarrij, Claire F Friedman, Samuel Freeman, et al.
Pageof 91